CERE
Cerevel Therapeutics Holdings, Inc.
General Counsel Scott Akamine sold $676K of Cerevel Therapeutics Holdings, Inc.
Sold$676,200
$38.64Price
17,500Shares
−97%Stake
What CERE did after the filing
- The stock from Fri, Dec 8 open, $41.13
- +2.1%
- S&P 500, same days
- +6.5%
Measured over 30 trading days, to the Jan 24 close.
Traded Tue, Dec 5. Filed Thu, Dec 7, 7:45 PM ET, after the close. Returns use the Dec 8 open and the Jan 24 close. Not investment advice.